Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Or Yat Sun. Insider active across 1 company, notably Enanta Pharmaceuticals INC. In total, 22 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €70k. Activity tracked since 19 November 2021. The latest transaction was filed on 12 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Or Yat Sun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,650 shares0Common StockSEC:0002064832-26-000008:0
2,390 shares@ US$14.237.8% of flowCommon StockSEC:0002064832-25-000059:0
753 shares@ US$14.122.4% of flowCommon StockSEC:0002064832-25-000044:0
9,750 shares0Common StockSEC:0001062993-25-002558:0
2,591 shares@ US$8.065.2% of flowCommon StockSEC:0001062993-24-020380:0
1,595 shares@ US$8.603.4% of flowCommon StockSEC:0001062993-24-019982:0
3,680 shares0Common StockSEC:0001062993-24-003229:0
2,412 shares@ US$9.635.6% of flowCommon StockSEC:0001062993-23-022049:0
1,595 shares@ US$9.493.6% of flowCommon StockSEC:0001062993-23-021985:0
13,925 shares@ US$14.0047.7% of flowCommon StockSEC:0001062993-23-007221:0
10,250 shares0Common StockSEC:0001062993-23-003715:0
1,055 shares@ US$44.3311.8% of flowCommon StockSEC:0001062993-22-023363:0
21,000 shares0Common StockSEC:0001062993-22-022846:0
615 shares0Common StockSEC:0001062993-22-004514:0
557 shares@ US$87.6811.5% of flowCommon StockSEC:0001062993-21-012201:0
6,800 shares0Common StockSEC:0001062993-21-011504:0
13,921 sharesCommon StockSEC:0000908662-16-000406:0
5,800 sharesCommon StockSEC:0000908662-16-000406:1
23,201 sharesCommon StockSEC:0000908662-16-000406:2
50,723 sharesCommon StockSEC:0000908662-16-000379:0
13,921 sharesCommon StockSEC:0000908662-16-000379:1
13,921 sharesCommon StockSEC:0000908662-16-000379:2
About Or Yat Sun
Or Yat Sun is Chief Scientific Officer at Enanta Pharmaceuticals INC (XNAS). The declarant has 22 filings in total, and among the sampled recent filings, transactions run from 2016-01-05 to 2026-02-13, with EUR 70371 in sales and EUR 0 in purchases; the modal transaction nature is Attribution.